Canadian Bioceutical Corp

Ordinary Shares International Reporting
Verified Company Profile 5/04/2017
Contact Info
  • Yonge Norton Centre
  • 5255 Yonge Street, Suite 701
  • Toronto, ONT M2N 6P4
  • Canada

Business Description

Financial Reporting/Disclosure
Reporting Status International Reporting: TSX Venture Exchange
Audited Financials Audited
Latest Report Dec 31, 2016 Quarterly Report
Fiscal Year End 3/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2833 - Medicinal and botanicals
Incorporated In: Canada
Year of Inc. 1974
Employees 90 a/o May 04, 2017
Company Officers/Contacts
W. Scott Boyes CEO, President
Randall G. Stafford CFO
Jeremy S. Budd General Counsel, Corporate Secretary, Vice President
Company Directors
Marilyn H. Bloovol Chairwoman
W. Scott Boyes
David J. Layman
Randall G. Stafford
Donald P. Stott
Company Notes
  • Formerly=Allegiance Equity Corp until 12-2014
Service Providers
Accounting/Auditing Firm
Deloitte LLP
2 New Street Square
London, EC4A 3BZ
United Kingdom

Legal Counsel
PO Box 70043
Rimrock Plaza PO
Toronto, ONT, M5V 3B6

Investor Relations Firm
National Equicom
800 - 6 Avenue SW
Calgary, ALB, T2P 3G3

CBICF Security Details
Share Structure
Market Value1 $62,106,027 a/o Sep 21, 2017
Authorized Shares Unlimited a/o May 04, 2017
Outstanding Shares 252,668,946 a/o Apr 26, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 240,595,887 a/o May 04, 2017
Par Value Not Available
Transfer Agent(s) Verified by Transfer Agent
Shareholders of Record 173 a/o May 04, 2017
Non US Stock Exchange Listing
BCC - TSX Venture Exchange - Qualified
Short Selling Data
Short Interest 67,515 (19.96%)
Aug 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security